BlackRock Group’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-43,467
Closed -$1.5M 2959
2014
Q4
$1.5M Sell
43,467
-1,995
-4% -$65.1K ﹤0.01% 1639
2014
Q3
$1.36M Buy
45,462
+19,408
+74% +$411K ﹤0.01% 1605
2014
Q2
$523K Sell
26,054
-20,145
-44% -$462K ﹤0.01% 2181
2014
Q1
$1.26M Buy
46,199
+5,688
+14% +$151K ﹤0.01% 1875
2013
Q4
$840K Sell
40,511
-11,937
-23% -$225K ﹤0.01% 2044
2013
Q3
$955K Buy
52,448
+14,870
+40% +$269K ﹤0.01% 1929
2013
Q2
$624K Buy
+37,578
New +$600K ﹤0.01% 1995

Other funds holding AUXL

BlackRock Group's AUXL Position: Q1 2015 in Review

BlackRock Group sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 43,467 shares — an estimated $1.5M sold.

BlackRock Group first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $1.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • BlackRock Group reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Group sold 43,467 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $1.5M.
  • BlackRock Group first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Group's AUXILIUM PHARAMCEUTICALS INC position peaked at $1.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on BlackRock Group's 13F filing for Q1 2015, filed 13 May 2015.